• 1. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Benzonitrile, 4-[(2,2,2-trifluoroethyl)amino]-2-(trifluoromethyl)- (CAS No. 821777-50-8): A Comprehensive Overview in Modern Chemical Research

The compound Benzonitrile, 4-[(2,2,2-trifluoroethyl)amino]-2-(trifluoromethyl)-, identified by its CAS number 821777-50-8, represents a significant advancement in the realm of chemical synthesis and pharmaceutical development. This specialized molecule has garnered considerable attention due to its unique structural features and potential applications in various scientific domains. The presence of both trifluoromethyl and trifluoroethyl substituents imparts distinct electronic and steric properties, making it a valuable candidate for further exploration.

In recent years, the integration of fluorine-containing groups into organic molecules has become increasingly prevalent, driven by their ability to modulate metabolic stability, lipophilicity, and binding affinity. The compound in question exemplifies this trend, combining a benzonitrile core with amino functionalities that are further modified by fluorinated side chains. Such structural motifs are particularly attractive in drug discovery pipelines, where they can enhance the pharmacokinetic profiles of candidate molecules.

The synthesis of Benzonitrile, 4-[(2,2,2-trifluoroethyl)amino]-2-(trifluoromethyl)- involves sophisticated methodologies that leverage modern catalytic techniques and purification strategies. Advanced computational methods have been employed to optimize reaction pathways, ensuring high yields and minimal byproduct formation. These efforts align with the broader goal of sustainable chemistry, where efficiency and environmental impact are given equal consideration.

One of the most compelling aspects of this compound is its potential application in the development of novel therapeutic agents. The combination of a benzonitrile moiety with fluorinated amino groups creates a scaffold that can interact with biological targets in unique ways. For instance, studies have suggested that such molecules may exhibit inhibitory activity against certain enzymes or receptors implicated in inflammatory diseases and cancer. The trifluoromethyl group, in particular, is known to enhance binding interactions due to its electron-withdrawing nature.

Recent research has also explored the use of this compound as an intermediate in the synthesis of more complex molecules. Its versatile reactivity allows for further functionalization, enabling chemists to construct intricate structures with tailored properties. This adaptability makes it a valuable tool for medicinal chemists who are tasked with designing molecules that meet stringent pharmacological requirements.

The impact of fluorine substitution on the electronic properties of organic compounds cannot be overstated. In the case of Benzonitrile, 4-[(2,2,2-trifluoroethyl)amino]-2-(trifluoromethyl)-, these effects contribute to enhanced metabolic stability and improved oral bioavailability. These characteristics are critical for drug candidates that must withstand the rigors of biological systems while maintaining efficacy. The compound’s potential to serve as a building block for next-generation therapeutics is therefore substantial.

From a computational chemistry perspective, the study of this molecule has provided new insights into the role of fluorine atoms in modulating molecular interactions. Advanced modeling techniques have been used to predict how changes in substituent placement affect binding affinities and pharmacokinetic parameters. These predictions are validated through experimental studies, reinforcing the reliability of computational approaches in drug discovery.

The future prospects for Benzonitrile, 4-[(2,2,2-trifluoroethyl)amino]-2-(trifluoromethyl)- extend beyond its immediate applications in pharmaceuticals. Its structural features make it a promising candidate for materials science research as well. For example, derivatives of this compound could be explored as precursors for advanced polymers or liquid crystals that exhibit novel optical or electronic properties.

In conclusion, the compound Benzonitrile, 4-[(2,2,2-trifluoroethyl)amino]-2-(trifluoromethyl)- (CAS No. 821777-50-8) represents a significant advancement in chemical synthesis and pharmaceutical development. Its unique structural features and potential applications across multiple scientific domains underscore its importance as a research tool and a candidate for future therapeutics. As our understanding of fluorinated compounds continues to grow，so too will their impact on innovation in chemistry and medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)